IQVIA Holdings Inc. announced the appointment of Ron Bruehlman as interim Chief Financial Officer, succeeding Mike McDonnell who is leaving the company to become Chief Financial Officer of Biogen Inc. Ron was previously the Chief Financial Officer of IMS Health from 2011 until the merger of IMS Health and Quintiles in 2016. Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib, Chairman and CEO of IQVIA. During this time, Ron regularly participated in key management meetings, operational reviews, preparation of quarterly earnings reports, and board meetings, providing on-going guidance and support to Mike and the senior finance team. In addition, Ron currently serves as Chairman of the Board of Directors at Second Quarter Solutions, an IQVIA and Quest Diagnostics joint venture and a leading clinical trial laboratory services organization. Prior to joining IMS Health, Ron had a 23-year career at United Technologies Corporation (UTC). Mr. Bruehlman’s appointment is effective from August 1, 2020.